Immune evasion in cell-based immunotherapy: unraveling challenges and novel strategies

Abstract Cell-based immunotherapies (CBIs), notably exemplified by chimeric antigen receptor (CAR)-engineered T (CAR-T) cell therapy, have emerged as groundbreaking approaches for cancer therapy. Nevertheless, akin to various other therapeutic modalities, tumor cells employ counterstrategies to mani...

Full description

Bibliographic Details
Published in:	Journal of Biomedical Science
Main Authors:	Yan-Ruide Li, Tyler Halladay, Lili Yang
Format:	Article
Language:	English
Published:	BMC 2024-01-01
Subjects:	Immune evasion Cell-based immunotherapies (CBIs) Chimeric antigen receptor (CAR) CAR-engineered T (CAR-T) cell therapy Tumor microenvironment (TME) Immune checkpoint proteins
Online Access:	https://doi.org/10.1186/s12929-024-00998-8

Similar Items

An Ex Vivo 3D Tumor Microenvironment-Mimicry Culture to Study TAM Modulation of Cancer Immunotherapy
by: Yan-Ruide Li, et al.
Published: (2022-05-01)

Tumor Microenvironment Immunosuppression: A Roadblock to CAR T-Cell Advancement in Solid Tumors
by: Abigail Cheever, et al.
Published: (2022-11-01)

CAR-T Cells/-NK Cells in Cancer Immunotherapy and the Potential of MSC to Enhance Its Efficacy: A Review
by: Ler Yie Chan, et al.
Published: (2022-03-01)

Immune evasion, dysregulation, and emerging immunotherapies for invasive fungal infections in the immunocompromised host
by: Haiying Liu, et al.
Published: (2026-04-01)

The Emergence of Universal Immune Receptor T Cell Therapy for Cancer
by: Nicholas G. Minutolo, et al.
Published: (2019-03-01)

Checkpoint antibody receptor modified ARMed CAR T circumvents the suppressive immunome in GBM
by: Danielle R. Cook, et al.
Published: (2025-07-01)

Immune evader cancer stem cells direct the perspective approaches to cancer immunotherapy
by: Hassan Dianat-Moghadam, et al.
Published: (2022-04-01)

A Novel Peptide-MHC Targeted Chimeric Antigen Receptor T Cell Forms a T Cell-like Immune Synapse
by: Stacie Shiqi Wang, et al.
Published: (2021-12-01)

Research progress on chimeric antigen receptor-based immunotherapy against autoimmune diseases
by: Mingwei Jiang, et al.
Published: (2025-12-01)

The Role of NK Cells in Cancer Immunotherapy: Mechanisms, Evasion Strategies, and Therapeutic Advances
by: Paula Morcillo-Martín-Romo, et al.
Published: (2025-04-01)

Editorial: Innovative immunotherapy strategies for enhanced treatment of Hodgkin and non-Hodgkin lymphomas
by: Michael J. Robertson, et al.
Published: (2025-06-01)

Immune Escape in Glioblastoma: Mechanisms of Action and Implications for Immune Checkpoint Inhibitors and CAR T-Cell Therapy
by: Catherine Yu, et al.
Published: (2023-12-01)

Towards a Systems Immunology Approach to Unravel Responses to Cancer Immunotherapy
by: Laura Bracci, et al.
Published: (2020-10-01)

Genetic engineering strategies to enhance antitumor reactivity and reduce alloreactivity for allogeneic cell-based cancer therapy
by: Yuning Chen, et al.
Published: (2023-03-01)

From Cancer to Immune-Mediated Diseases and Tolerance Induction: Lessons Learned From Immune Oncology and Classical Anti-cancer Treatment
by: Stephan Klöß, et al.
Published: (2020-07-01)

The Notch signaling pathway: a potential target for cancer immunotherapy
by: Xinxin Li, et al.
Published: (2023-05-01)

Barriers to overcoming immunotherapy resistance in glioblastoma
by: Julia S. Gillette, et al.
Published: (2023-05-01)

Harnessing natural killer cells to develop next‐generation cellular immunotherapy
by: Siyao Liu, et al.
Published: (2022-12-01)

Chimeric antigen receptor technology: an emerging translational immunotherapy in nonneoplastic diseases
by: Sijie Zhou, et al.
Published: (2026-06-01)

Recent findings on chimeric antigen receptor (CAR)-engineered immune cell therapy in solid tumors and hematological malignancies
by: Ali Keshavarz, et al.
Published: (2022-09-01)

Advancements in CRISPR screens for the development of cancer immunotherapy strategies
by: Yan-Ruide Li, et al.
Published: (2023-12-01)

Human epidermal growth factor receptor 2 (HER2)-specific chimeric antigen receptor (CAR) for tumor immunotherapy; recent progress
by: Hendrik Setia Budi, et al.
Published: (2022-01-01)

Natural Receptor- and Ligand-Based Chimeric Antigen Receptors: Strategies Using Natural Ligands and Receptors for Targeted Cell Killing
by: Gianna M. Branella, et al.
Published: (2021-12-01)

Current progress and emerging trends of car-based immunotherapy for hepatocellular carcinoma: a data-driven atlas from multidatabase integration
by: Hao Ying, et al.
Published: (2026-04-01)

Immunotherapy of glioblastoma: Recent advances and future prospects
by: Boyang Yuan, et al.
Published: (2022-11-01)

CAR-Based Therapy for Autoimmune Diseases: A Novel Powerful Option
by: Györgyi Műzes, et al.
Published: (2023-06-01)

CAR-T cells: Early successes in blood cancer and challenges in solid tumors
by: Hassan Dana, et al.
Published: (2021-05-01)

Editorial: Achilles heel of CAR T-cell therapy
by: Maurizio Chiriva-Internati, et al.
Published: (2025-10-01)

Direct visualization of chimeric antigen receptors on primary human T cells using dSTORM super-resolution microscopy
by: Leon Gehrke, et al.
Published: (2025-08-01)

Progress and pitfalls of gene editing technology in CAR-T cell therapy: a state-of-the-art review
by: Vahid Moradi, et al.
Published: (2024-06-01)

CAR-NKT cell therapy: a new promising paradigm of cancer immunotherapy
by: Kaveh Hadiloo, et al.
Published: (2023-05-01)

The affinity of antigen-binding domain on the antitumor efficacy of CAR T cells: Moderate is better
by: Rui Mao, et al.
Published: (2022-10-01)

The landscape of chimeric antigen receptor T cell therapy in breast cancer: Perspectives and outlook
by: Hao Zhang, et al.
Published: (2022-07-01)

Decoding the immune microenvironment: precision immunotherapy for medulloblastoma subtypes
by: Mengyuan Li, et al.
Published: (2026-04-01)

Expanding the Horizons of CAR-T Cell Therapy: A Review of Therapeutic Targets Across Diverse Diseases
by: Alejandrina Hernández-López, et al.
Published: (2025-01-01)

Combining chemotherapy with CAR-T cell therapy in treating solid tumors
by: Arthur Xuan Wang, et al.
Published: (2023-03-01)

New therapeutics for soft tissue sarcomas: Overview of current immunotherapy and future directions of soft tissue sarcomas
by: Gyuhee Seong, et al.
Published: (2023-03-01)

Newest Approaches in Immunotherapy for Non-Hodgkin’s Lymphoma
by: Emily C. Ayers, et al.
Published: (2018-12-01)

Therapeutic targets of armored chimeric antigen receptor T cells navigating the tumor microenvironment
by: Xianjun Li, et al.
Published: (2024-09-01)

Chimeric Antigen Receptor (CAR)-T Cell Therapy for Non-Hodgkin’s Lymphoma
by: Maria Giraudo, et al.
Published: (2024-03-01)